Natixis Advisors LLC Trims Position in Select Medical Holdings Co. (NYSE:SEM)

Natixis Advisors LLC cut its position in Select Medical Holdings Co. (NYSE:SEM) by 4.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 25,299 shares of the health services provider’s stock after selling 1,161 shares during the period. Natixis Advisors LLC’s holdings in Select Medical were worth $882,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. GAMMA Investing LLC grew its stake in Select Medical by 16.6% during the third quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock valued at $81,000 after acquiring an additional 330 shares in the last quarter. Foster & Motley Inc. grew its stake in Select Medical by 3.1% during the second quarter. Foster & Motley Inc. now owns 12,147 shares of the health services provider’s stock valued at $426,000 after acquiring an additional 370 shares in the last quarter. KBC Group NV grew its stake in Select Medical by 4.5% during the third quarter. KBC Group NV now owns 13,050 shares of the health services provider’s stock valued at $455,000 after acquiring an additional 563 shares in the last quarter. Arizona State Retirement System grew its stake in Select Medical by 2.0% during the second quarter. Arizona State Retirement System now owns 30,544 shares of the health services provider’s stock valued at $1,071,000 after acquiring an additional 593 shares in the last quarter. Finally, Hexagon Capital Partners LLC grew its stake in Select Medical by 528.7% during the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 645 shares in the last quarter. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Stock Performance

Shares of NYSE:SEM opened at $20.35 on Thursday. Select Medical Holdings Co. has a 52 week low of $20.00 and a 52 week high of $40.98. The stock has a market capitalization of $2.63 billion, a P/E ratio of 9.51, a PEG ratio of 1.73 and a beta of 1.42. The firm has a fifty day simple moving average of $34.69 and a two-hundred day simple moving average of $34.90. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. During the same period last year, the company posted $0.46 EPS. The business’s revenue was up 5.7% on a year-over-year basis. On average, analysts expect that Select Medical Holdings Co. will post 2.16 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were paid a dividend of $0.125 per share. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.46%. Select Medical’s dividend payout ratio is presently 23.36%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Benchmark cut shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday. StockNews.com cut shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Thursday, November 21st. Bank of America began coverage on shares of Select Medical in a research note on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price objective for the company. Finally, Royal Bank of Canada lifted their price objective on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Select Medical has an average rating of “Hold” and a consensus price target of $40.75.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.